Healthcare >> Analyst Interviews >> August 3, 2000

Biotechnology Stocks : Carol Werther – Adams, Harkness & Hill

Carol Werther is a Senior Analyst in Biotechnology at Summer Street Research Partners. Prior to joining the company, she worked as a biotechnology consultant for several firms, including Winslow Management and Rx Capital. She has also held senior biotechnology analyst positions at Think Equity and Adams Harkness & Hill. She was recognized by The Wall Street Journal's "Best on the Street Survey" in 2000 and 2001. She received an MBA degree from New York University, Stern School of Business, and holds an MS degree and a BS degree in Nutrition Sciences from the University of Alabama in Birmingham and Cornell University, respectively. Profile
TWST: Carol, what distinguishes the approach that you at Adams Harkness

& Hill take to investing in biotechnology?

Ms. Werther: The primary objective at Adams is to provide